Sources: US News
The British government signs an agreement to secure 480,000 courses of Molnupiravir produced by Merck Sharp and Dohme, and 250,000 courses of Ritonavir produced by Pfizer, where both of them need to be approved by health regulator. 2021-10-20
South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine. 2021-08-13
A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective. 2021-06-14
Kosovo signs an agreement with Pfizer to buy 1.2 million doses of the Pfizer–BioNTech vaccine, with the vaccine rollout expected to begin on June 15. 2021-05-28
King Salman receives the first dose of Pfizer's vaccine in Neom. 2021-01-8
Singapore officially begins its vaccination campaign against COVID-19, with healthcare workers being among the first to receive the Pfizer-BioNTech vaccine tozinameran. 2020-12-30
Swissmedic approves the authorization of the Pfizer-BioNTech vaccine for use in Switzerland. 2020-12-19
Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021. 2020-12-14
The Health Ministry announces that Spain will receive 20 million vaccine doses from Pfizer and BioNTech by early 2021. 2020-11-10